Adaptin Bio (APTN) Selling, General & Administrative (2023 - 2026)
Adaptin Bio (APTN) reported Selling, General & Administrative of $1.06 million for Q2 2026, down 10.0% from $1.18 million a year earlier but up 8.6% from the prior quarter.
Powered by 
Analysis
Adaptin Bio (APTN) Selling, General & Administrative (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Adaptin Bio's Selling, General & Administrative came in at $3.71 million, up 46.7% year-over-year; for FY2025, it was $3.64 million, up 388.5% from FY2024.
- Selling, General & Administrative has increased for three consecutive years, with a three-year compound annual growth rate of 407.8% (FY2022 to FY2025).
- By year, Selling, General & Administrative came in at $745,294 in FY2024 (+770.7%), $85,593 in FY2023 (+207.8%) and $27,804 in FY2022.
- Five-year quarterly Selling, General & Administrative spans a low of $34,155 in Q4 2023 and a high of $1.18 million in Q2 2025.
- Year over year, Selling, General & Administrative gained in six of the last seven quarters, with growth averaging 336.1%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $978,576 (Q1 2026), $774,983 (Q4 2025) and $896,948 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Adaptin Bio | 56.76 Mn | 54.75 Mn | - | 1.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.06 Mn |
| Mar 31, 2026 | 978,576.00 |
| Dec 31, 2025 | 774,983.00 |
| Sep 30, 2025 | 896,948.00 |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 788,325.00 |
| Dec 31, 2024 | 250,022.00 |
| Sep 30, 2024 | 312,203.00 |
| Jun 30, 2024 | 82,292.00 |
| Mar 31, 2024 | 100,777.00 |
| Dec 31, 2023 | 34,155.00 |
| Sep 30, 2023 | 42,938.00 |
API Access
Adaptin Bio Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=APTN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "APTN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=APTN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();